Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of budesonide may be an effective way to prevent
bronchial dysplasia.
PURPOSE: Randomized double-blinded phase II trial to determine the effectiveness of
budesonide in treating former or current smokers who have bronchial dysplasia.